000 | 01995 a2200637 4500 | ||
---|---|---|---|
005 | 20250514003025.0 | ||
264 | 0 | _c20010726 | |
008 | 200107s 0 0 eng d | ||
022 | _a0270-9139 | ||
024 | 7 |
_a10.1053/jhep.2001.25636 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSaracco, G | |
245 | 0 | 0 |
_aA randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone. _h[electronic resource] |
260 |
_bHepatology (Baltimore, Md.) _cJul 2001 |
||
300 |
_a133-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAlanine Transaminase _xblood |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aHepacivirus _xgenetics |
650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInterferon alpha-2 |
650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aRNA, Viral _xblood |
650 | 0 | 4 | _aRecombinant Proteins |
650 | 0 | 4 |
_aRibavirin _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aViremia |
700 | 1 | _aCiancio, A | |
700 | 1 | _aOlivero, A | |
700 | 1 | _aSmedile, A | |
700 | 1 | _aRoffi, L | |
700 | 1 | _aCroce, G | |
700 | 1 | _aColletta, C | |
700 | 1 | _aCariti, G | |
700 | 1 | _aAndreoni, M | |
700 | 1 | _aBiglino, A | |
700 | 1 | _aCalleri, G | |
700 | 1 | _aMaggi, G | |
700 | 1 | _aTappero, G F | |
700 | 1 | _aOrsi, P G | |
700 | 1 | _aTerreni, N | |
700 | 1 | _aMacor, A | |
700 | 1 | _aDi Napoli, A | |
700 | 1 | _aRinaldi, E | |
700 | 1 | _aCiccone, G | |
700 | 1 | _aRizzetto, M | |
773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 34 _gno. 1 _gp. 133-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1053/jhep.2001.25636 _zAvailable from publisher's website |
999 |
_c11360979 _d11360979 |